We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
-21.51%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$8.43B
AUM Growth
-$8.39B
Cap. Flow
-$5.17B
Cap. Flow %
-61.29%
Top 10 Hldgs %
10.82%
Holding
1,704
New
583
Increased
218
Reduced
300
Closed
598

Sector Composition

Rank Sector Weight
1 Healthcare 14.11%
2 Technology 13.97%
3 Financials 13.54%
4 Consumer Discretionary 12.99%
5 Industrials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRUB
51
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$32.4M 0.38%
+398,307
New +$39.2M
WEX icon
52
WEX
WEX
$6.35B
$32.2M 0.38%
307,694
+176,296
+134% +$32.9M
PNR icon
53
Pentair
PNR
$10.7B
$31.4M 0.37%
1,056,672
+423,427
+67% +$17M
SAIC icon
54
Saic
SAIC
$5.35B
$31.4M 0.37%
421,310
+322,646
+327% +$26.9M
MLCO icon
55
Melco Resorts & Entertainment
MLCO
$2.14B
$31.4M 0.37%
2,533,192
+745,221
+42% +$14.2M
TIF
56
DELISTED
Tiffany & Co.
TIF
$31.4M 0.37%
242,303
-339,683
-58% -$44.7M
BMRN icon
57
BioMarin Pharmaceuticals
BMRN
$13.3B
$31M 0.37%
366,292
-258,125
-41% -$22.2M
OPTU
58
Optimum Communications Inc
OPTU
$299M
$30.7M 0.36%
1,379,203
-879,106
-39% -$23M
AKAM icon
59
Akamai
AKAM
$16.9B
$30.4M 0.36%
332,767
-172,732
-34% -$16M
CONE
60
DELISTED
CyrusOne Inc Common Stock
CONE
$30.3M 0.36%
+490,755
New +$30M
MSGS icon
61
Madison Square Garden
MSGS
$9.4B
$30.3M 0.36%
200,719
+36,699
+22% +$7.12M
CVS icon
62
CVS Health
CVS
$122B
$30.1M 0.36%
507,297
+179,133
+55% +$12M
DXCM icon
63
DexCom
DXCM
$33.1B
$29.5M 0.35%
438,344
-24,972
-5% -$1.55M
WMB icon
64
Williams Companies
WMB
$87.7B
$29.5M 0.35%
2,083,039
+1,985,799
+2,042% +$38.5M
MO icon
65
Altria Group
MO
$110B
$29.2M 0.35%
+754,763
New +$33.5M
LRCX icon
66
Lam Research
LRCX
$385B
$29.2M 0.35%
1,215,560
+64,350
+6% +$1.85M
BLK icon
67
Blackrock
BLK
$175B
$28.9M 0.34%
65,643
+50,877
+345% +$25.1M
ALL icon
68
Allstate
ALL
$68.4B
$28.7M 0.34%
+313,089
New +$34M
BIIB icon
69
PUT
Biogen
BIIB
$30.6B
$28.5M 0.34%
+90,000
New +$27.3M
SNY icon
70
Sanofi
SNY
$104B
$28.4M 0.34%
650,092
+6,818
+1% +$326K
NVO
71
Novo Nordisk
NVO
$208B
$28.1M 0.33%
934,456
-459,528
-33% -$13.7M
XLU icon
72
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.4B
$28M 0.33%
+1,012,000
New +$32.4M
ADM icon
73
Archer Daniels Midland
ADM
$38.7B
$27.5M 0.33%
782,180
+111,500
+17% +$4.56M
ASML icon
74
ASML
ASML
$673B
$27.4M 0.33%
104,813
+50,612
+93% +$14.4M
CXO
75
DELISTED
CONCHO RESOURCES INC.
CXO
$27.3M 0.32%
636,192
+301,300
+90% +$21M

Similar funds

Balyasny Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Balyasny Asset Management held 1,704 positions worth $8.43B, down 50% from $16.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management withdrew a net $5.17B in Q1 2020, closing 598 positions and reducing 300 holdings. Its most notable exit was American International, an estimated $193M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 10% a quarter earlier, followed by Technology and Financials.

Against the trend, Balyasny Asset Management opened a new position in Lowe's Companies worth $86M.

  • Balyasny Asset Management's largest Q1 2020 buy was Lowe's Companies: 999,686 shares worth $86M.
  • Balyasny Asset Management added most to Boston Scientific in Q1 2020, an estimated $72.4M increase.
  • Balyasny Asset Management's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $121M.
  • Balyasny Asset Management fully exited American International in Q1 2020, selling an estimated $193M.
  • Balyasny Asset Management's ten largest holdings make up 11% of its $8.43B portfolio in Q1 2020.
  • Balyasny Asset Management opened 583 new positions and closed 598 in Q1 2020.
  • Balyasny Asset Management's portfolio value fell 50% quarter-over-quarter to $8.43B.

Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.